Nuveen Asset Management, LLC Sensei Biotherapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.49 - $2.3 $78,159 - $120,648	-52,456 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.22 - $6.07 $2,017 - $5,517	909 Added 1.76%	52,456 $133,000
Q4 2021 Feb 14, 2022	SELL	$4.85 - $10.48 $23,289 - $50,324	-4,802 Reduced 8.52%	51,547 $271,000
Q3 2021 Nov 12, 2021	BUY	$6.89 - $11.99 $301,871 - $525,317	43,813 Added 349.5%	56,349 $548,000
Q2 2021 Aug 16, 2021	BUY	$9.1 - $15.14 $1,783 - $2,967	196 Added 1.59%	12,536 $122,000
Q1 2021 May 17, 2021	BUY	$12.04 - $22.75 $148,573 - $280,735	12,340 New	12,340 $179,000

2.23M

Ticker SNSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,720,300
Market Cap $15.4M
Description
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.